Plasma and human milk concentrations of moclobemide in nursing mothers
β Scribed by Anne Buist; Lorraine Dennerstein; Kay P. Maguire; Trevor R. Norman
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 70 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
β¦ Synopsis
Plasma and breast milk concentrations of the monoamine oxidase-A inhibitor, moclobemide were measured in eight women being treated for post-partum depression. The main milk to plasma ratio was 0 . 68, with a range of 0 . 39Β±1 . 21. There was no correlation between this ratio and dose of the drug. Based on the milk to plasma ratio, the infants were exposed to 51% of the maternal dose. This exposure did not appear to have any adverse eects on the infants' developmental milestones as judged by clinical observation. Long term follow up of these children and further study of within day variations in plasma and breast milk moclobemide after chronic dosage are required.
π SIMILAR VOLUMES
## Abstract **BACKGROUND:** The role of maternal zinc nutrition in human oral clefts (OCs) is unclear. We measured plasma zinc concentrations (PZn) of case and control mothers to evaluate the associations between PZn and risk of OCs with and without other malformations. **METHODS:** Case mothers we
An HPLC method was developed for the determination of zonisamide in human breast milk and plasma. Chromatographic separation was achieved using a Develosil CN analytical column with potassium dihydrogenphosphate buffer (pH 3.5 with milk, pH 2.5 with plasma)-acetonitrile as the mobile phase. Zonisami
## Abstract ## BACKGROUND Findings from animal experiments suggest a link between poor maternal zinc status and increased risk of oral clefts in offspring; however, there are few human studies on this issue. ## METHODS A caseβcontrol study was conducted using 74 case mothers of children with non